HK1128490A1 - Selection of host cells expressing protein at high levels - Google Patents

Selection of host cells expressing protein at high levels

Info

Publication number
HK1128490A1
HK1128490A1 HK09107655.2A HK09107655A HK1128490A1 HK 1128490 A1 HK1128490 A1 HK 1128490A1 HK 09107655 A HK09107655 A HK 09107655A HK 1128490 A1 HK1128490 A1 HK 1128490A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
interest
selectable marker
host cells
coding
Prior art date
Application number
HK09107655.2A
Other languages
English (en)
Inventor
Arie Pieter Otte
Henricus Johannes Maria Van Blokland
Theodorus Hendrikus Jacobus Kwaks
Richard George Antonius Bernardus Sewalt
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/359,953 external-priority patent/US20060141577A1/en
Priority claimed from US11/416,490 external-priority patent/US20060195935A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Publication of HK1128490A1 publication Critical patent/HK1128490A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK09107655.2A 2006-02-21 2009-08-20 Selection of host cells expressing protein at high levels HK1128490A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/359,953 US20060141577A1 (en) 2004-11-08 2006-02-21 Selection of host cells expressing protein at high levels
EP06113354 2006-05-02
US11/416,490 US20060195935A1 (en) 2004-11-08 2006-05-02 Selection of host cells expressing protein at high levels
PCT/EP2007/051696 WO2007096399A2 (en) 2006-02-21 2007-02-21 Selection of host cells expressing protein at high levels

Publications (1)

Publication Number Publication Date
HK1128490A1 true HK1128490A1 (en) 2009-10-30

Family

ID=38324190

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107655.2A HK1128490A1 (en) 2006-02-21 2009-08-20 Selection of host cells expressing protein at high levels

Country Status (14)

Country Link
EP (2) EP1987150B1 (xx)
JP (1) JP5225107B2 (xx)
KR (1) KR101328300B1 (xx)
CN (2) CN101389763B (xx)
AT (2) ATE511544T1 (xx)
AU (1) AU2007247242B2 (xx)
CA (2) CA2637271C (xx)
DK (2) DK1987150T3 (xx)
EA (1) EA014332B1 (xx)
HK (1) HK1128490A1 (xx)
PL (1) PL1987150T3 (xx)
PT (1) PT1987150E (xx)
SI (1) SI1987150T1 (xx)
WO (2) WO2007096399A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572994B1 (en) 2002-12-20 2007-02-21 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
PT2385115E (pt) 2008-12-22 2015-11-24 Univ Hokkaido Nat Univ Corp Vetor de expressão para produção de proteína derivada de gene exógeno em grandes quantidades usando células animais e seu uso
CA2753814C (en) 2009-02-27 2018-07-31 Novartis Ag Novel selection vectors and methods of selecting eukaryotic host cells
US8765370B2 (en) * 2009-06-11 2014-07-01 Scinopharm Taiwan, Ltd Inhibition-based high-throughput screen strategy for cell clones
EP2443239B1 (en) 2009-06-15 2015-11-25 Cellagenics B.V. Novel stringent selectable markers
WO2011113841A1 (en) * 2010-03-16 2011-09-22 Robert Steinfeld Eukaryotic vector
EP2572706A4 (en) * 2010-04-21 2014-02-26 Univ Hokkaido Nat Univ Corp Lipid membrane structure with nucleic acid transportability
BR112012031694A2 (pt) * 2010-06-15 2016-02-16 Cellagenics B V fragmento de ácido nucleíco, construto de ácido nucleíco, vetor de expressão, célula hospedeira, método de geração de uma célula hospedeira para a expressão de um produto gênico de interesse, e, método de expresão de um produto de gene de interesse
WO2012030218A1 (en) 2010-09-01 2012-03-08 Cellagenics B.V. Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
JP6576924B2 (ja) 2013-07-31 2019-09-18 ノバルティス アーゲー 新規の選択ベクターおよび真核宿主細胞を選択する方法
CN104531699B (zh) * 2014-10-09 2017-03-15 河南农业大学 一种增强外源基因表达的猪的ucoe调控元件片段
CN106754817B (zh) * 2016-11-03 2021-02-05 山西省生物研究院有限公司 一种重组自分泌运动因子的表达方法
DE102017103383A1 (de) * 2017-02-20 2018-08-23 aReNA-Bio GbR (vertretungsberechtigter Gesellschafter: Dr. Heribert Bohlen, 50733 Köln) System und Verfahren zur Zelltyp-spezifischen Translation von RNA-Molekülen in Eukaryoten
JP2021532439A (ja) * 2018-07-30 2021-11-25 ナンジン、ジェンスクリプト、バイオテック、カンパニー、リミテッドNanjing Genscript Biotech Co., Ltd. コドン最適化
WO2020036181A1 (ja) * 2018-08-13 2020-02-20 Ｓｐｉｂｅｒ株式会社 細胞を単離又は同定する方法及び細胞集団
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用
KR20210080071A (ko) * 2019-12-20 2021-06-30 (주)셀트리온 목적 단백질의 고발현을 위한 인트론을 포함하는 발현 카세트 및 이의 이용

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256568A (en) * 1990-02-12 1993-10-26 Regeneron Phamaceuticals, Inc. Vectors and transformed most cells for recombinant protein production with reduced expression of selectable markers
US6319707B1 (en) * 1991-08-12 2001-11-20 Fred Hutchinson Cancer Research Center Board Regents Of The University Of Washington Cap-independent multicistronic retroviral vectors
US5648267A (en) * 1992-11-13 1997-07-15 Idec Pharmaceuticals Corporation Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
WO1996012008A1 (en) * 1994-10-13 1996-04-25 Merck & Co., Inc. Synthesis of methylase-resistant genes
CA2723500C (en) * 2002-06-14 2014-10-28 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
NZ553700A (en) * 2004-11-08 2010-09-30 Chromagenics Bv Selection of host cells expressing protein at high levels using a selectable marker with a non-optimal start codon
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
JP5291341B2 (ja) * 2004-11-08 2013-09-18 クロマジェニックス ベー ヴェー タンパク質を高レベルで発現する宿主細胞の選定

Also Published As

Publication number Publication date
CN101437946B (zh) 2012-07-04
KR101328300B1 (ko) 2013-11-14
PT1987150E (pt) 2011-09-08
KR20080105034A (ko) 2008-12-03
EP1987150B1 (en) 2011-06-01
PL1987150T3 (pl) 2011-10-31
ATE511544T1 (de) 2011-06-15
CA2637271A1 (en) 2007-08-30
AU2007247242B2 (en) 2012-03-08
DK1987150T3 (da) 2011-09-19
EP2013349A1 (en) 2009-01-14
JP2009527240A (ja) 2009-07-30
EA200870279A1 (ru) 2009-02-27
CN101437946A (zh) 2009-05-20
WO2007096399A2 (en) 2007-08-30
WO2007128685A1 (en) 2007-11-15
DK2013349T3 (da) 2011-02-28
SI1987150T1 (sl) 2011-09-30
EA014332B1 (ru) 2010-10-29
CA2651088C (en) 2016-03-08
EP1987150A2 (en) 2008-11-05
CA2637271C (en) 2014-12-09
CN101389763B (zh) 2013-01-23
WO2007096399A3 (en) 2008-05-02
AU2007247242A1 (en) 2007-11-15
CA2651088A1 (en) 2007-11-15
AU2007217431A1 (en) 2007-08-30
JP5225107B2 (ja) 2013-07-03
CN101389763A (zh) 2009-03-18
EP2013349B1 (en) 2010-11-17
ATE488593T1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
HK1128490A1 (en) Selection of host cells expressing protein at high levels
ZA200702046B (en) Selection of host cells expressing protein at high levels
WO2006048459A3 (en) Selection of host cells expressing protein at high levels
Boussardon et al. Two interacting proteins are necessary for the editing of the NdhD-1 site in Arabidopsis plastids
WO2008005847A3 (en) Method of producing factor viii proteins by recombinant methods
WO2002029088A3 (en) Highly expressible genes
WO2010051049A3 (en) Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
AU2003238444A1 (en) The frog prince, a transposon vector for gene transfer in vertebrates
EP2061883A2 (en) Matrix attachment regions (mars) for increasing transcription and uses thereof
de Tacca et al. PTBP1 mRNA isoforms and regulation of their translation
WO2004013312A3 (en) Tocopherol biosynthesis related genes and uses thereof
Shetty et al. Molecular mechanism of selenoprotein P synthesis
Alexandrova et al. Elaborate uORF/IRES features control expression and localization of human glycyl-tRNA synthetase
Nomoto et al. Cloning‐free template DNA preparation for cell‐free protein synthesis via two‐step PCR using versatile primer designs with short 3′‐UTR
MX2008009219A (es) Elementos de control de expresion de la familia lemnaceae.
US9803207B2 (en) Expression vector for production of recombinant proteins in prokaryotic host cells
WO2006097945A3 (en) A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure
Mie et al. Selection of mRNA 5′-untranslated region sequence with high translation efficiency through ribosome display
US11578335B2 (en) Synthetic algal promoters
WO2009038841A3 (en) Portable, temperature and chemically inducible expression vector for high cell density expression of heterologous genes in escherichia coli
WO2006026611A3 (en) Reverse transcriptase mediated rna gene expression
CN116144703A (zh) 一种非洲爪蟾卵母细胞表达载体pGXBG
AU2001263920A1 (en) Method for the production of proteins in a yeast of the genusarxula and suitable promoters
Tao et al. Construction of a eukaryotic expression plasmid pcDNA3. 1-HuR-FLAG and its transient expression in NIH3T3 cells
NZ603077A (en) Biological materials and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220219